> ()*+ l \pThe Free Software Foundation B=PF0*8X@"1 Helvetica1Courier1Courier New1Courier New1 Helvetica$#,##0_);($#,##0)$#,##0_);[Red]($#,##0)$#,##0.00_);($#,##0.00)$#,##0.00_);[Red]($#,##0.00)**_($* #,##0_);_($* (#,##0);_($* ""_);_(@_)*)'_(* #,##0_);_(* (#,##0);_(* ""_);_(@_)5,2_($* #,##0.00_);_($* (#,##0.00);_($* ""??_);_(@_)2+/_(* #,##0.00_);_(* (#,##0.00);_(* ""??_);_(@_)2$#,##0.00;[Red]$#,##0.003$#,##0.00;[Red]($#,##0.00)4$#,##0;[Red]($#,##00)50.00%;[Red](0.00%)60%;[Red](0%)7#,##0.00;[Red](#,##0.00)8#,##0;[Red](#,##0) + ) , * Ј ~~ ؈ ~~#؈ ~~"؈ ~~7#܈ ~~ ؈ ~~"؈ ~~8#܈ ~~3"܈ ~~4#܈ ~~83ffff̙̙3f3fff3f3f33333f33
Indenture
EXHIBIT INDEX8+TABLE OF CONTENTSFTABLE OF CONTEN (1)eTABLE OF CONTEN (2)TABLE OF CONTEN (3)5CONVERSION OF NOTESJCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)3CONVERSION OF N (4)bCONVERSION OF N (5)$CONVERSION OF N (6)CONVERSION OF N (7)&1Remainder of page intentionally@:Remainder of page (1)BNANTHEALTH INCbNANTHEALTH INC (1)anNANTHEALTH INC (2)YxSignature Page Follows&ЂThe information in this pricing#*The information in this (1)#The information in this (2)Signature Page (1)#!The information in this (3)#^The information in this (4)#+The information in this (5)#)The information in this (6)CADVANCES
l +Ms
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }I }$ }:
+
NantHealth, Inc.8K
12/21/2016 Indenture Exhibit Description
No.ffffff@3+Indenture, dated December 21, 2016, between
/
'NantHealth, Inc. and U.S. Bank NationalAssociation.@1)Form of 5.50% Convertible Senior Note due'2021 (included in Exhibit 4.1).333333$@.&Purchase Agreement, dated December 15,/'2016, by and among NantHealth, Inc. and0(J.P. Morgan Securities LLC and Jefferies80LLC, as representative of the initial purchasersnamed therein.ffffff$@.&Purchase Agreement, dated December 15,1)2016, by and between NantHealth, Inc. and!Cambridge Equities, L.P..$@.&Second Amended and Restated Promissory5Note, dated December 15, 2016, by and between.&NantHealth, Inc. and Nant Capital LLC.DlzV Y){c(A !"#$%&'()* !fffffX@!/!'Press Release, dated December 15, 2016,""'"announcing launch of the Notes.##$X@$/$'Press Release, dated December 16, 2016,%%(% announcing pricing of the Notes.&'$(____________________________1))Created by Morningstar Document Research.0*(http://documentresearch.morningstar.com/T
@**))((
l +'*
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? IndentureTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }I }$ }:
+
NantHealth, Inc.8K
12/21/2016
EXHIBIT INDEX Exhibit Description
No.ffffff@3+Indenture, dated December 21, 2016, between
/
'NantHealth, Inc. and U.S. Bank NationalAssociation.@1)Form of 5.50% Convertible Senior Note due'2021 (included in Exhibit 4.1).333333$@.&Purchase Agreement, dated December 15,/'2016, by and among NantHealth, Inc. and0(J.P. Morgan Securities LLC and Jefferies80LLC, as representative of the initial purchasersnamed therein.ffffff$@.&Purchase Agreement, dated December 15,1)2016, by and between NantHealth, Inc. and!Cambridge Equities, L.P..$@.&Second Amended and Restated Promissory5Note, dated December 15, 2016, by and between.&NantHealth, Inc. and Nant Capital LLC.DlvR
U%
w_x$= !"#$%&'()* !fffffX@!/!'Press Release, dated December 15, 2016,""'"announcing launch of the Notes.##$X@$/$'Press Release, dated December 16, 2016,%%(% announcing pricing of the Notes.&'$(____________________________1))Created by Morningstar Document Research.0*(http://documentresearch.morningstar.com/T
@**))((
l =K:E
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$ }7}$ }}$
=
NantHealth, Inc.8K
12/21/2016TABLE OF CONTENTS
P AGE
ARTICLE 1
D EFINITIONS
Section 1.01.
Definitions
~
Section 1.02.References to Interest~
6 ARTICLE 2:2I SSUE , D ESCRIPTION , E XECUTION , R EGISTRATION"AND E XCHANGE OF N OTESSection 2.01 .Designation and Amount~
:
Section 2.02.
Form of Notes~
:
Section 2.03.0(Date and Denomination of Notes; Payments~
>)!of Interest and Defaulted Amounts
Section 2.04..&Execution, Authentication and Delivery~
Bof Notes
Section 2.05.%Exchange and Registration of Transfer~
F6.of Notes; Restrictions on Transfer; Depositary
Section 2.06.2*Mutilated, Destroyed, Lost or Stolen Notes~
n
Section 2.07.Temporary Notes~
r
Section 2.08..&Cancellation of Notes Paid, Converted,~
vEtc.D
l~rhuT
FK}Qwx !"#$%&'()*+,./0123456789:;<
Section 2.09.
CUSIP Numbers ~
v !
Section 2.10.!%!Additional Notes; Repurchases!!~
!v!"# ARTICLE 3#&$S ATISFACTION AND D ISCHARGE$%%%&Section 3.01 .&"&Satisfaction and Discharge&&~
&z&'( ARTICLE 4(3)+P ARTICULAR C OVENANTS OF THE C OMPANY)***+Section 4.01 .+)+!Payment of Principal and Interest++~
+z+,
Section 4.02.,',Maintenance of Office or Agency,,~
,z,
Section 4.03.3+Appointments to Fill Vacancies in Trustee?s~
~...Office/
Section 4.04./%/Provisions as to Paying Agent//~
/~/0
Section 4.05.00 Existence00~
001
Section 4.06.11%Rule 144A Information Requirement and11~
11222Annual Reports3
Section 4.07.3&3Stay, Extension and Usury Laws33~
334
Section 4.08.44%Compliance Certificate; Statements as44~
44555to Defaults6
Section 4.09.6$6Further Instruments and Acts66~
667
Section 4.10.7%7Limitations on Affiliate Debt77~
7789$:____________________________1;)Created by Morningstar Document Research.0<(http://documentresearch.morningstar.com/>0wp8D [=PF0*8X>
@j
<<;;::))(($$##
l CKV+d@e
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$ }U5}$ }$}$
C
NantHealth, Inc.8K
12/21/2016TABLE OF CONTENTS
ARTICLE 5
?7L ISTS OF H OLDERS AND R EPORTS BY THE C OMPANYAND THE T RUSTEE
Section 5.01 .Lists of Holders~
Section 5.02.,$Preservation and Disclosure of Lists~
ARTICLE 6!D EFAULTS AND R EMEDIESSection 6.01 .Events of Default~
Section 6.02..&Acceleration; Rescission and Annulment~
Section 6.03.Additional Interest~
Section 6.04.3+Payments of Notes on Default; Suit Therefor~
Section 6.05.2*Application of Monies Collected by Trustee~
Section 6.06.Proceedings by Holders~
Section 6.07.Proceedings by Trustee~
Section 6.08.*"Remedies Cumulative and Continuing~
Section 6.09..&Direction of Proceedings and Waiver of~
'Defaults by Majority of Holders
Section 6.10.Notice of Defaults~
Section 6.11. Undertaking to Pay Costs~
D_l~r`eY8noTbT !"#$%&'()*+,./0123456789:;<=>? ! ARTICLE 7!""C ONCERNING THE T RUSTEE"###$Section 7.01 .$.$&Duties and Responsibilities of Trustee$$~
$$%
Section 7.02.%%%Reliance on Documents, Opinions, Etc.%%~
%%&
Section 7.03.&,&$No Responsibility for Recitals, Etc.&&~
&&'
Section 7.04.'2'*Trustee, Paying Agents, Conversion Agents,''~
''((0((Bid Solicitation Agent or Note Registrar)))
May Own Notes*
Section 7.05.*4*,Monies and Shares of Common Stock to Be Held**~
**+++in Trust,
Section 7.06.,,,$Compensation and Expenses of Trustee,,~
,,
Section 7.07.4,Officer?s Certificate and Opinion of Counsel~
...as Evidence/
Section 7.08.//Eligibility of Trustee//~
//0
Section 7.09.0)0!Resignation or Removal of Trustee00~
001
Section 7.10.1'1Acceptance by Successor Trustee11~
112
Section 7.11.2"2Succession by Merger, Etc.22~
223
Section 7.12.3.3&Trustee?s Application for Instructions33~
33444from the Company56 ARTICLE 86"7C ONCERNING THE H OLDERS78889Section 8.01 .99Action by Holders99~
99:
Section 8.02.:%:Proof of Execution by Holders::~
::;
Section 8.03.;&;Who Are Deemed Absolute Owners;;~
;;<
Section 8.04.<'<CompanyOwned Notes Disregarded<<~
<<=
Section 8.05.=.=&Revocation of Consents; Future Holders==~
==>>
>Bound?D
l}kWK a[U!)(@AB$@____________________________1A)Created by Morningstar Document Research.0B(http://documentresearch.morningstar.com/
(=PF0*8X>
@bBBAA@@7766""!!
l D8un
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$ }:}$ }$}$
D
NantHealth, Inc.8K
12/21/2016TABLE OF CONTENTS
ARTICLE 9
H OLDERS ? M EETINGS
Section 9.01 .
Purpose of Meetings
~
Section 9.02.#Call of Meetings by Trustee~
Section 9.03..&Call of Meetings by Company or Holders~
Section 9.04.!Qualifications for Voting~
Section 9.05.Regulations~
Section 9.06.Voting~
Section 9.07.%No Delay of Rights by Meeting~
ARTICLE 10"S UPPLEMENTAL I NDENTURESSection 10.01 ./'Supplemental Indentures Without Consent~
of HoldersSection 10.02.,$Supplemental Indentures with Consent~
of HoldersSection 10.03.)!Effect of Supplemental Indentures~
Section 10.04.Notation on Notes~
Section 10.05..&Evidence of Compliance of Supplemental~
)!Indenture to Be Furnished TrusteeD
l~r*#9PD"@\b !"#$%&'()*+,./0123456789:;<=>? !
ARTICLE 11!6".C ONSOLIDATION , M ERGER , S ALE , C ONVEYANCE"#AND L EASE$$$%Section 11.01 .%0%(Company May Consolidate, Etc. on Certain%%~
%%&&
&Terms'Section 11.02.'/''Successor Corporation to Be Substituted''~
''(Section 11.03.(1()Opinion of Counsel to Be Given to Trustee((~
(()*
ARTICLE 12*7+/I MMUNITY OF I NCORPORATORS , S TOCKHOLDERS ,+",O FFICERS AND D IRECTORS.Section 12.01 ..8.0Indenture and Notes Solely Corporate Obligations..~
../0
ARTICLE 1301 R ESERVED123
ARTICLE 1434C ONVERSION OF N OTES45556Section 14.01.66Conversion Privilege66~
667Section 14.02.77%Conversion Procedure; Settlement Upon77~
77888
Conversion9Section 14.03.9,9$Increased Conversion Rate Applicable99~
99::2:*to Certain Notes Surrendered in Connection;;+;#with MakeWhole Fundamental Changes<Section 14.04.<%<Adjustment of Conversion Rate<<~
<<=Section 14.05.==Adjustments of Prices==~
=B=>Section 14.06.>>Shares to Be Fully Paid>>~
>B>?D
luQwU/#_^0Z@ABC@$A____________________________1B)Created by Morningstar Document Research.0C(http://documentresearch.morningstar.com/<=PF0*8X>
@CCBBAA44331100,,++**##""!!
l @\
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$ }y<}$ }$}$
@
NantHealth, Inc.8K
12/21/2016TABLE OF CONTENTS Section 14.07. 6 .Effect of Recapitalizations, Reclassifications ~
F
'
and Changes of the Common StockSection 14.08.Certain Covenants~
NSection 14.09.!Responsibility of Trustee~
N
Section 14.10.
2
*Notice to Holders Prior to Certain Actions
~
R
Section 14.11. Stockholder Rights Plans~
RSection 14.12.&Exchange in Lieu of Conversion~
V
ARTICLE 15:2R EPURCHASE OF N OTES AT O PTION OF H OLDERSSection 15.01 .[Intentionally Omitted]~
VSection 15.02.:2Repurchase at Option of Holders Upon a Fundamental~
VChangeSection 15.03.3+Withdrawal of Fundamental Change Repurchase~
bNoticeSection 15.04.0(Deposit of Fundamental Change Repurchase~
b
PriceSection 15.05./'Covenant to Comply with Applicable Laws~
f Upon Repurchase of Notes
ARTICLE 16N O R EDEMPTIONDl~rIWMS/d: !"#$%&'()*+,./0123456789:;<=>? !Section 16.01.!!
No Redemption!!~
!f!"#
ARTICLE 17##$M ISCELLANEOUS P ROVISIONS$%%%&Section 17.01 .&2&*Provisions Binding on Company?s Successors&&~
&j&'Section 17.02.'.'&Official Acts by Successor Corporation''~
'j'(Section 17.03.(#(Addresses for Notices, Etc.((~
(j()Section 17.04.)#)Governing Law; Jurisdiction))~
)j)*Section 17.05 .*.*&Evidence of Compliance with Conditions**~
*n*++,+$Precedent; Certificates and Opinions,,,of Counsel to TrusteeSection 17.06 .Legal Holidays~
n.Section 17.07 ..$.No Security Interest Created..~
.r./Section 17.08 .//Benefits of Indenture//~
/r/0Section 17.09.0)0!Table of Contents, Headings, Etc.00~
0r01Section 17.10 .11Authenticating Agent11~
1r12Section 17.11 .2!2Execution in Counterparts22~
2v23Section 17.12 .33Severability33~
3v34Section 17.13 .44Waiver of Jury Trial44~
4v45Section 17.14 .55
Force Majeure55~
5v56Section 17.15 .66Calculations66~
6z67Section 17.16.77USA PATRIOT Act77~
7z789EXHIBIT9: Exhibit A::Form of Note:::A1:;<$=____________________________1>)Created by Morningstar Document Research.0?(http://documentresearch.morningstar.com/D'
lk_=
WNDPUWh}n=PF0*8X>
@R
??>>==99$$##
l e
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }0}$ }
}$ }
}
$ }
}$ }}$ }}$ }}$ }}$ }} "$ }##}$&$ }''}(($
)))))))))) )
)))
)))))))))NantHealth, Inc.8K
12/21/2016CONVERSION OF NOTES
!"#$%&'( Stock Price (
Effective Date
Qk#@
~
.
HzG(@
~
>
1@
~
R
~
f
~
z
!~
"
$
%~
&
(December 21, 20164@:H/1@
6 ,@
_L5"@):?@ׁs@0*@ڊe? !"#$C?$%&~
'(December 15, 20174@(\/@
8d`)@
H@m4@K7@:p@z):? !"#Ǻ?$%&~
'(
December 15, 2018
4@
fj+@
EGr%@
K=@
(
>@
@
Zd;O?
ׁ?
!
"
#Oec?
$
%
&~
'
(December 15, 20194@{P(@
!@
?W[l@{P
@37@镲?
h"lxz? !"#
h"lxz?$%&~
'(December 15, 20204@sk$@
!uq@
o@]Fx?io?鷯?HP? !"#Q?$%&~
'(December 15, 20214@9#
!@
~
~
~
~
~
~
!"~
#$%&~
'($____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/0pIr=ymE=PF0*8X>
@r(((
"#
&' '
l $F{
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$ }$}$ }:
$
NantHealth, Inc.8K
12/21/2016CONVERSION OF NOTES where,
CR 0 =1)the Conversion Rate in effect immediately80prior to the open of business on the ExDividend
.
&Date of such dividend or distribution,4,or immediately prior to the open of business1)on the Effective Date of such share split,$or share combination, as applicable;CR? =1)the Conversion Rate in effect immediately6.after the open of business on such ExDividendDate or Effective Date;OS 0 =80the number of shares of Common Stock outstanding1)immediately prior to the open of business3+on such ExDividend Date or Effective Date;andOS? =80the number of shares of Common Stock outstanding/'immediately after giving effect to such.÷nd, distribution, share split orshare combination.D
lp4d.iEr%[& !"# $!____________________________1")Created by Morningstar Document Research.0#(http://documentresearch.morningstar.com/<=PF0*8X>
@##""!!
l )&
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$ }$}$ }y<
)
NantHealth, Inc.8K
12/21/2016CONVERSION OF NOTES where,
CR 0 =1)the Conversion Rate in effect immediately80prior to the open of business on the ExDividend
Date for such issuance;CR? =1)the Conversion Rate in effect immediately6.after the open of business on such ExDividend
Date;OS 0 =80the number of shares of Common Stock outstanding1)immediately prior to the open of business!on such ExDividend Date; X =2*the total number of shares of Common Stock1)issuable pursuant to such rights, optionsor warrants; and Y =2*the number of shares of Common Stock equal2*to the aggregate price payable to exercise1)such rights, options or warrants, divided0(by the average of the Last Reported Sale:2Prices of the Common Stock over the 10 consecutiveD
lp4dmIsU !"#$%&'( 4 ,Trading Day period ending on, and including,!!!!!%the Trading Day immediately preceding""""0"(the date of announcement of the issuance####,#$of such rights, options or warrants.$%$&____________________________1')Created by Morningstar Document Research.0((http://documentresearch.morningstar.com/7sg[3=PF0*8X>
@((''&&
l $
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$ }$}$ }:
$
NantHealth, Inc.8K
12/21/2016CONVERSION OF NOTES where,
CR 0 =1)the Conversion Rate in effect immediately80prior to the open of business on the ExDividend
#
Date for such distribution;CR? =1)the Conversion Rate in effect immediately5after the open of business on the ExDividend#Date for such distribution;SP 0 =4,the average of the Last Reported Sale Prices3+of the Common Stock over the 10 consecutive4,Trading Day period ending on, and including,%the Trading Day immediately preceding3+the ExDividend Date for such distribution;andFMV =/'the fair market value (as determined by2*the Board of Directors) of the Distributed1)Property with respect to each outstanding4,share of the Common Stock on the ExDividend#Date for such distribution.D
lp4d}T0\,b/ !"# $!____________________________1")Created by Morningstar Document Research.0#(http://documentresearch.morningstar.com/<=PF0*8X>
@##""!!
l 
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$ }$}$ }8

NantHealth, Inc.8K
12/21/2016CONVERSION OF NOTES where,
CR 0 =1)the Conversion Rate in effect immediately1)prior to the end of the Valuation Period;
CR? =1)the Conversion Rate in effect immediately.&after the end of the Valuation Period;
FMV 0 =4,the average of the Last Reported Sale Prices7/of the Capital Stock or similar equity interest2*distributed to holders of the Common Stock3+applicable to one share of the Common Stock2*(determined by reference to the definition0(of Last Reported Sale Price as set forth0(in Section 1.01 as if references therein2*to Common Stock were to such Capital Stock2*or similar equity interest) over the first0(10 consecutive Trading Day period after,.&and including, the ExDividend Date of0(the SpinOff (the ? Valuation Period ?);2*provided that if there is no last reported2*sale price of the Capital Stock or similar.&equity interest distributed to holdersDlp4dr~FL" !"#$%&'()*+, 1 )of Common Stock on such ExDividend Date,!!!!/!'the Valuation Period shall be the first""""1")ten consecutive Trading Day period after,####7#/and including the first date such Last Reported$$$$$$Sale Price is available; and%%%&MP 0& &=&4&,the average of the Last Reported Sale Prices''''6'.of the Common Stock over the Valuation Period.()$*____________________________1+)Created by Morningstar Document Research.0,(http://documentresearch.morningstar.com/8h =PF0*8X>
@,,++**
l
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$ }$}$ }:
NantHealth, Inc.8K
12/21/2016CONVERSION OF NOTES where,
CR 0 =1)the Conversion Rate in effect immediately80prior to the open of business on the ExDividend
/
'Date for such dividend or distribution;CR? =1)the Conversion Rate in effect immediately5after the open of business on the ExDividend/'Date for such dividend or distribution;SP 0 =2*the Last Reported Sale Price of the Common6.Stock on the Trading Day immediately preceding.&the ExDividend Date for such dividendor distribution; and C =0(the amount in cash per share the Company/'distributes to all or substantially all$holders of the Common Stock.$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/D lp4dq<CmL@4=PF0*8X>
@
l
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$ }$}$ }8
NantHealth, Inc.8K
12/21/2016CONVERSION OF NOTES where,
CR 0 =1)the Conversion Rate in effect immediately2*prior to the close of business on the 10th
.
&Trading Day immediately following, and2*including, the Trading Day next succeeding7/the date such tender or exchange offer expires;CR? =1)the Conversion Rate in effect immediately7/after the close of business on the 10th Trading1)Day immediately following, and including,0(the Trading Day next succeeding the date.&such tender or exchange offer expires;$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/:p4d6>n
h=PF0*8X>
@
l (.1
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$ }$}$ }:
(
NantHealth, Inc.8K
12/21/2016CONVERSION OF NOTES
AC
=
5
the aggregate value of all cash and any other1)consideration (as determined by the Board0(of Directors) paid or payable for shares
0
(of Common Stock purchased in such tenderor exchange offer;OS 0 =80the number of shares of Common Stock outstanding1)immediately prior to the date such tender2*or exchange offer expires (prior to giving6.effect to the purchase of all shares of Common/'Stock accepted for purchase or exchange*"in such tender or exchange offer);OS? =80the number of shares of Common Stock outstanding.&immediately after the date such tender/'or exchange offer expires (after giving6.effect to the purchase of all shares of Common/'Stock accepted for purchase or exchange.&in such tender or exchange offer); andSP? =4,the average of the Last Reported Sale Prices3+of the Common Stock over the 10 consecutiveDalp4?w)/_z
Ex !"#$%&' 8 0Trading Day period commencing on, and including,!!!!0!(the Trading Day next succeeding the date""""."&such tender or exchange offer expires.#$$%____________________________1&)Created by Morningstar Document Research.0'(http://documentresearch.morningstar.com/{0=PF0*8X>
@''&&%%
l 9
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)Remainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$ }
NantHealth, Inc.8K
12/21/20164,[Remainder of page intentionally left blank] NANTHEALTH, INC.
By:
Name:
Title:$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/*h{ocW3ymE=PF0*8X>
@"
l \B
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyNANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }1
NantHealth, Inc.8K
12/21/20164,[Remainder of page intentionally left blank] Dated:
/'TRUSTEE?S CERTIFICATE OF AUTHENTICATION&
U.S. BANK NATIONAL ASSOCIATION1)as Trustee, certifies that this is one ofthe Notes described&in the withinnamed Indenture.$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/0{ocWK9pF:.=PF0*8X>
@
l )]a
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$
)
NantHealth, Inc.8K
12/21/2016NANTHEALTH, INC.
Date of exchange Amount of Amount of
Principal amount
Signature of
decrease in
increase in
of this Global Note
authorizedprincipal amountprincipal amount
following such
signatory ofof this Global Noteof this Global Note
decrease or
Trustee or
increase
Custodian
Dls
@u$X(\,` !"#$%&'(
!!!!!!!!!! !
!!!
!!!"""""""""" "
"""
"""########## #
###
###$%$&____________________________1')Created by Morningstar Document Research.0((http://documentresearch.morningstar.com/4h=PF0*8X>
@((''&&
l $ln
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }8
$
NantHealth, Inc.8K
12/21/2016NANTHEALTH, INC.0 (with membership in an approved signature,
$guarantee medallion program pursuant%to Securities and Exchange Commission2*Rule 17Ad15 if shares of Common Stock are3
+to be issued, or Notes are to be delivered,7/other than to and in the name of the registeredholder.0(Fill in for registration of shares if to0(be issued, and Notes if to be delivered,7/other than to and in the name of the registeredholder:(Name)(Street Address)"(City, State and Zip Code)%Please print name and addressDlsg3e*hUI=+ !"# $!____________________________1")Created by Morningstar Document Research.0#(http://documentresearch.morningstar.com/<=PF0*8X>
@
l w
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }8
NantHealth, Inc.8K
12/21/2016NANTHEALTH, INC.
Signature(s))
!Social Security or Other TaxpayerIdentification Number3+Principal amount to be repaid (if less thanall): $ ,0007/NOTICE: The above signature(s) of the Holder(s)/'hereof must correspond with the name as2*written upon the face of the Note in every4,particular without alteration or enlargementor any change whatever.$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/>v0sg[C7+v;wk_7=PF0*8X>
@
l
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$
NantHealth, Inc.8K
12/21/2016 [Signature Page Follows] Initial Purchaser Principal Amount of
Underwritten Securities"J.P. Morgan Securities LLC~
Jefferies LLC~
Cowen and Company, LLC
~
Canaccord Genuity Inc.~
BT
Total~
*u$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/2wk/TI=PF0*8X>
@R
l *
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page FollowsThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }2}$ }y<
*
NantHealth, Inc.8K
12/21/2016kcThe information in this pricing term sheet supplements NantHealth, Inc. s preliminary offering memo Issuer: 1 )NantHealth, Inc., a Delaware corporation.
2*Ticker/Exchange for Issuer?s Common Stock:%?NH?/The NASDAQ Global Select Market.
Notes:
0
(5.50% Convertible Senior Notes due 2021.Principal Amount:91$90,000,000, plus up to an additional $15,000,0000(principal amount pursuant to the initial1)purchasers? option to purchase additionalNotes.Affiliated Investor::2An entity affiliated with Dr. Patrick SoonShiong,1)the Issuer?s Chairman and Chief Executive3+Officer, has agreed to purchase $10,000,000/'principal amount of Notes in a separate2*concurrent private placement under Section1)4(a)(2) of the Securities Act of 1933, as%amended (the ?Securities Act?), which/'is in addition to $90,000,000 principal4,amount of Notes being sold in this offering.1)Notes purchased by such affiliated entity/'will be issued in certificated form andD lD8, 5rZT n%r !"#$%&'() . &will be subject to additional transfer!!!%restrictions applicable to Notes held""/"'by the Issuer?s affiliates as described##8#0under ?Transfer Restrictions? in the Preliminary$$$Offering Memorandum.%&$'____________________________1()Created by Morningstar Document Research.0)(http://documentresearch.morningstar.com/m"~V=PF0*8X>
@))((''
l Q
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }$4}$ }=
Q
NantHealth, Inc.8K
12/21/2016kcThe information in this pricing term sheet supplements NantHealth, Inc. s preliminary offering memo Issue Price: 1 )100% of principal, plus accrued interest,
)
!if any, from the Settlement Date.Trade Date:December 16, 2016.
Settlement Date:December 21, 2016.3+Last Reported Sale Price of Issuer?s Common$9.71 per share.#Stock on December 15, 2016: Initial Conversion Rate:/'82.3893 shares of Issuer?s Common Stock%per $1,000 principal amount of Notes.!Initial Conversion Price:2*Approximately $12.14 per share of Issuer?s
Common Stock.Conversion Premium:3+Approximately 25.0% above the Last Reported;3Sale Price of Issuer?s Common Stock on December 15,~
$Joint BookRunning Managers:"J.P. Morgan Securities LLC
Jefferies LLCDlD8, ^F0 E}, !"#$%&'()*+,./0123456789:;<=>?
Lead Manager: Cowen and Company, LLC!!"CoManager:""Canaccord Genuity, Inc.##+$#CUSIP Number (144A / Regulation S):$$
630104 AA5%%#&ISIN (144A / Regulation S):&&US630104AA56''(Use of Proceeds:(/('Issuer estimates that the aggregate net))6).proceeds from this offering and the concurrent**1*)private placement to an affiliated entity++/+'will be approximately $96.2 million (or,,0,($110.7 million if the initial purchasers4,exercise their option to purchase additional..0.(Notes in full), after deducting fees and///%estimated expenses. Issuer expects to0020*use the net proceeds from the offering for111%general corporate purposes, which may222%include commercializing new solutions33.3&and product extensions and potentially4404(pursuing targeted acquisitions. See ?Use5505(of proceeds? in the Preliminary Offering666Memorandum.7738+Increase in Conversion Rate Upon Conversion818)Following the occurrence of a ?makewhole39+in Connection with a MakeWhole Fundamental9.9&fundamental change? (as defined in the:Change:::%Preliminary Offering Memorandum), the;;0;(Issuer will increase the Conversion Rate<<4<,for a holder who elects to convert its Notes==6=.in connection with such makewhole fundamental>>5>change in certain circumstances, as described??.?&under ?Description of notes?ConversionDNl[Cw}2Jj!?o@ABCDEFGHIJKLMNOP@@/@'Rights?Increase in conversion rate uponAA0A(conversion upon a makewhole fundamentalBB7B/change? in the Preliminary Offering Memorandum.CCCDDDEE1E)The following table sets forth the numberFF4F,of additional shares by which the ConversionGG3G+Rate will be increased per $1,000 principalHH5Hamount of Notes for conversions in connectionII0I(with a makewhole fundamental change forJJ/J'each ?stock price? and ?effective date?KKKset forth below:LM$N____________________________1O)Created by Morningstar Document Research.0P(http://documentresearch.morningstar.com/&7@i1E=PF0*8X>
@PPOONN
l
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }0}$ }
}$ }
}
$ }
}$ }}$ }}$ }}$ }}$ }} "$ }##}$&$ }''}(($
)))))))))) )
)))
)))))))))NantHealth, Inc.8K
12/21/2016kcThe information in this pricing term sheet supplements NantHealth, Inc. s preliminary offering memo
!"#$%&'( Stock Price (
Effective Date
Qk#@
~
.
HzG(@
~
>
1@
~
R
~
f
~
z
!~
"
$
%~
&
(December 21, 20164@:H/1@
6 ,@
_L5"@):?@ׁs@0*@ڊe? !"#$C?$%&~
'(December 15, 20174@(\/@
8d`)@
H@m4@K7@:p@z):? !"#Ǻ?$%&~
'(
December 15, 2018
4@
fj+@
EGr%@
K=@
(
>@
@
Zd;O?
ׁ?
!
"
#Oec?
$
%
&~
'
(December 15, 20194@{P(@
!@
?W[l@{P
@37@镲?
h"lxz? !"#
h"lxz?$%&~
'(December 15, 20204@sk$@
!uq@
o@]Fx?io?鷯?HP? !"#Q?$%&~
'(December 15, 20214@9#
!@
~
~
~
~
~
~
!"~
#$%&~
'($____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/0,D8, 4W"N5)=PF0*8X>
@r(((
"#
&' '
l !~
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)The information in this (3)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }}$ }
!
NantHealth, Inc.8K
12/21/2016 [Signature Page Follows] Very truly yours,
2*Name of Security Holder (Print exact name)
By: Signature1)If not signing in an individual capacity:%Name of Authorized Signatory (Print ).&Title of Authorized Signatory (Print )/'(indicate capacity of person signing if3+signing as custodian, trustee, or on behalf
of an entity)$____________________________1)Created by Morningstar Document Research.DlwkG*pd/#]&
0 (http://documentresearch.morningstar.com/H=PF0*8X>
@Z
l 
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (4)The information in this (5)The information in this (6)
ADVANCESU }2}$ }y<

NantHealth, Inc.8K
12/21/2016kcThe information in this pricing term sheet supplements NantHealth, Inc. s preliminary offering memo Issuer: 1 )NantHealth, Inc., a Delaware corporation.
2*Ticker/Exchange for Issuer?s Common Stock:%?NH?/The NASDAQ Global Select Market.
Notes:
0
(5.50% Convertible Senior Notes due 2021.Principal Amount:91$90,000,000, plus up to an additional $15,000,0000(principal amount pursuant to the initial1)purchasers? option to purchase additionalNotes.Affiliated Investor::2An entity affiliated with Dr. Patrick SoonShiong,1)the Issuer?s Chairman and Chief Executive3+Officer, has agreed to purchase $10,000,000/'principal amount of Notes in a separate2*concurrent private placement under Section1)4(a)(2) of the Securities Act of 1933, as%amended (the ?Securities Act?), which/'is in addition to $90,000,000 principal4,amount of Notes being sold in this offering.1)Notes purchased by such affiliated entity/'will be issued in certificated form andD lD8, 5rZT n%r !"#$%&'()*+, . &will be subject to additional transfer!!!%restrictions applicable to Notes held""/"'by the Issuer?s affiliates as described##8#0under ?Transfer Restrictions? in the Preliminary$$$Offering Memorandum.%%&Denominations:&0&($1,000 and multiples of $1,000 in excess'''thereof.()$*____________________________1+)Created by Morningstar Document Research.0,(http://documentresearch.morningstar.com/m"~$=PF0*8X>
@,,++**
l \K
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (5)The information in this (6)
ADVANCESU }$4}$ }y<
\
NantHealth, Inc.8K
12/21/2016kcThe information in this pricing term sheet supplements NantHealth, Inc. s preliminary offering memo Maturity: 5 December 15, 2021, unless earlier repurchased
or converted.Interest Rate:5.50% per year.
Interest Payment Dates:.&Interest will accrue from December 21,0(2016 and will be payable semiannually in2*arrears on June 15 and December 15 of each)!year, beginning on June 15, 2017.Interest Record Dates:7/June 1 and December 1 of each year, immediately5preceding any June 15 or December 15 interest)!payment date, as the case may be.$Interest MakeWhole Payment:3+On or after the date that is one year after1)the last date of original issuance of the1)notes, if the last reported sale price of1)the Issuer?s Common Stock for at least 201)trading days (whether or not consecutive)3+during the period of 30 consecutive trading0(days ending within the five trading days/'immediately preceding a conversion date:2is greater than or equal to 120% of the conversionD lD8, qYS?&?W !"#$%&'()*+,./0123456789:;<=>? 1 )price on each applicable trading day, the!!/!'Issuer will make an interest makewhole""2"*payment (an ?interest makewhole payment?)##7#/to a converting holder (other than a conversion$$3$+in connection with a makewhole fundamental%%8%0change in which the conversion rate is adjusted)&&1&)equal to the sum of the present values of''/''the scheduled payments of interest that((9(1would have been made on the notes to be converted))0)(had such notes remained outstanding from**/*'the conversion date through the earlier++1+)of (i) the date that is three years after,,1,)the conversion date and (ii) the maturity4,date if the notes had not been so converted...4.,The present values of the remaining interest//2/*payments will be computed using a discount000rate equal to 2.0%.112222*The Issuer may pay any interest makewhole3323*payment either in cash or in shares of its44/4'Common Stock, at the Issuer?s election.5505(If the Issuer elects to pay any interest6636+makewhole payment in cash it will pay cash7757in an amount equal to the interest makewhole8818)payment. If the Issuer does not make such99890election, the payment of any interest makewhole::0:(payment shall be in its Common Stock. If;;8;0the Issuer elects, or is deemed to have elected,<<.<&to pay any interest makewhole payment==1=)by delivering shares of its Common Stock,>>9>1the number of shares of common Stock a converting??0?(holder of notes will receive will be theDlhx$7Sf{GU k@ABCDEFGHIJKLMNOPQRSTUVWXYZ[@@0@(number of shares that have a value equalAA0A(to the amount of the interest makewholeBB3B+payment to be paid to such holder in sharesCC0C(of the Issuer?s Common Stock, divided byDD1D)the product of (x) 95% and (y) the simpleEE1E)average of the daily VWAP of the Issuer?sFF3F+Common Stock for the 10 trading days endingGG4G,on and including the trading day immediatelyHH&Hpreceding the conversion date.IIJJ,J$See ?Description of notes?ConversionKK/K'rights?Interest makewhole payment uponLL/L'certain conversions? in the PreliminaryMMMOffering Memorandum.NNOIssue Price:O1O)100% of principal, plus accrued interest,PP)P!if any, from the Settlement Date.QQRTrade Date:RRDecember 16, 2016.SSTSettlement Date:TTDecember 21, 2016.UU3V+Last Reported Sale Price of Issuer?s CommonVV$9.71 per share.#WStock on December 15, 2016:X$Y____________________________1Z)Created by Morningstar Document Research.0[(http://documentresearch.morningstar.com/<h3R:\$nV@
=PF0*8X>
@[[ZZYY
l G1')
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (6)
ADVANCESU }$4}$ }=
G
NantHealth, Inc.8K
12/21/2016kcThe information in this pricing term sheet supplements NantHealth, Inc. s preliminary offering memo Initial Conversion Rate: / '82.3893 shares of Issuer?s Common Stock

%per $1,000 principal amount of Notes.!Initial Conversion Price:2*Approximately $12.14 per share of Issuer?s
Common Stock.Conversion Premium:3+Approximately 25.0% above the Last Reported;3Sale Price of Issuer?s Common Stock on December 15,~
$Joint BookRunning Managers:"J.P. Morgan Securities LLC
Jefferies LLC
Lead Manager:Cowen and Company, LLCCoManager:Canaccord Genuity, Inc.+#CUSIP Number (144A / Regulation S):
630104 AA5#ISIN (144A / Regulation S):US630104AA56Use of Proceeds:/'Issuer estimates that the aggregate net6.proceeds from this offering and the concurrentDlD8, P8&7I1}e !"#$%&'()*+,./0123456789:;<=>? 1 )private placement to an affiliated entity!!/!'will be approximately $96.2 million (or""0"($110.7 million if the initial purchasers##4#,exercise their option to purchase additional$$0$(Notes in full), after deducting fees and%%%%estimated expenses. Issuer expects to&&2&*use the net proceeds from the offering for'''%general corporate purposes, which may(((%include commercializing new solutions)).)&and product extensions and potentially**0*(pursuing targeted acquisitions. See ?Use++0+(of proceeds? in the Preliminary Offering,,,Memorandum.3.+Increase in Conversion Rate Upon Conversion.1.)Following the occurrence of a ?makewhole3/+in Connection with a MakeWhole Fundamental/./&fundamental change? (as defined in the0Change:00%Preliminary Offering Memorandum), the1101(Issuer will increase the Conversion Rate2242,for a holder who elects to convert its Notes3363.in connection with such makewhole fundamental4454change in certain circumstances, as described55.5&under ?Description of notes?Conversion66/6'Rights?Increase in conversion rate upon7707(conversion upon a makewhole fundamental8878/change? in the Preliminary Offering Memorandum.999:::;;1;)The following table sets forth the number<<4<,of additional shares by which the Conversion==3=+Rate will be increased per $1,000 principal>>5>amount of Notes for conversions in connection??0?(with a makewhole fundamental change forDlh7W
uF.AUh~Z6J@ABCDEF@@/@'each ?stock price? and ?effective date?AAAset forth below:BC$D____________________________1E)Created by Morningstar Document Research.0F(http://documentresearch.morningstar.com/xuiA=PF0*8X>
@FFEEDD
l C
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)
ADVANCESU }0}$ }
}$ }
}
$ }
}$ }}$ }}$ }}$ }}$ }} "$ }##}$&$ }''}(($
)))))))))) )
)))
)))))))))NantHealth, Inc.8K
12/21/2016kcThe information in this pricing term sheet supplements NantHealth, Inc. s preliminary offering memo
!"#$%&'( Stock Price (
Effective Date
Qk#@
~
.
HzG(@
~
>
1@
~
R
~
f
~
z
!~
"
$
%~
&
(December 21, 20164@:H/1@
6 ,@
_L5"@):?@ׁs@0*@ڊe? !"#$C?$%&~
'(December 15, 20174@(\/@
8d`)@
H@m4@K7@:p@z):? !"#Ǻ?$%&~
'(
December 15, 2018
4@
fj+@
EGr%@
K=@
(
>@
@
Zd;O?
ׁ?
!
"
#Oec?
$
%
&~
'
(December 15, 20194@{P(@
!@
?W[l@{P
@37@镲?
h"lxz? !"#
h"lxz?$%&~
'(December 15, 20204@sk$@
!uq@
o@]Fx?io?鷯?HP? !"#Q?$%&~
'(December 15, 20214@9#
!@
~
~
~
~
~
~
!"~
#$%&~
'($____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/0,D8, 4W"N5)=PF0*8X>
@r(((
"#
&' '
l O
dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? Indenture
EXHIBIT INDEXTABLE OF CONTENTSTABLE OF CONTEN (1)TABLE OF CONTEN (2)TABLE OF CONTEN (3)CONVERSION OF NOTESCONVERSION OF N (1)CONVERSION OF N (2)CONVERSION OF N (3)CONVERSION OF N (4)CONVERSION OF N (5)CONVERSION OF N (6)CONVERSION OF N (7)!Remainder of page intentionallyRemainder of page (1)NANTHEALTH INCNANTHEALTH INC (1)NANTHEALTH INC (2)Signature Page Follows!The information in this pricingThe information in this (1)The information in this (2)Signature Page (1)The information in this (3)The information in this (4)The information in this (5)The information in this (6)U }}$ }$}
$
NantHealth, Inc.8K
12/21/2016ADVANCES
Date of Advance ! Original Principal Amount Amount and Date(s) of Outstanding Principal
of Advance
Prepayments of Advance
Balance of AdvanceJanuary 4, 2016~
:N/A~
:
TOTAL~
:N/A~
:
$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/.{9%qui]5=PF0*8X>
@Z
Root Entry FBook
O
!"#$%&'()*+,./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{}~
!"#$%&'